Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population

Internal and Emergency Medicine

Volumn 6, Issue 1, 2011, Pages 35-39

  Gatta, Luigi ^a,b   Di Mario, Francesco ^b   Vaira, Dino ^c   Franzé, Angelo ^d   Rugge, Massimo ^e   Pilotto, Alberto ^f   Lucarini, Paolo ^a   Lera, Maurizio ^a   Fiorini, Giulia ^c   Castelli, Valentina ^c   Kajo, Enkleda ^c   Scarpignato, Carmelo ^b  

^a Versilia Hospital   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Parma Hospital   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Eradication therapy; Helicobacter pylori; Immigrant population

Indexed keywords

EID: 85027934900     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0443-0     Document Type: Article

References (28)

1. Vakil N, Megraud F (2007) Eradication therapy for Helicobacter pylori. Gastroenterology 133: 985-1001.
2. Zullo A, Hassan C, Andriani A et al (2009) Eradication therapy for Helicobacter pylori in patients with gastric MALT-Lymphoma: a pooled-data analysis. Am J Gastroenterol 104(8): 1932-1937.
3. Capacci F, Carnevale F, Gazzano N (2005) The health of foreign workers in Italy. Int J Occup Environ Health 11: 64-69.
4. Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22: 283-297.
5. Matysiak-Budnik T, Megraud F (1994) Helicobacter pylori in eastern European countries: what is the current status? Gut 35: 1683-1686.
6. Malfertheiner P, Megraud F, O'Morain C et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 56: 772-781.
7. Newcombe R, Altman D (2000) Proportion and their differences. In: Altman D, Machin D, Trevor N et al (eds) Statistics with confidences. BMJ Books, London, pp 45-56.
8. Vakil N, Vaira D (2008) Sequential therapy for Helicobacter pylori: time to consider making the switch? JAMA 300: 1346-1347.
9. Chey WD, Wong BC (2007) American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102: 1808-1825.
10. Cavallaro LG, Egan B, O'Morain C et al (2006) Treatment of Helicobacter pylori infection. Helicobacter 11(Suppl 1): 36-39.
11. Vakil N, Lanza F, Schwartz H et al (2004) Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther 20: 99-107.
12. Gatta L, Vakil N, Leandro G et al (2009) Sequential therapy or triple therapy for Helicobacter Pylori infection: systematic review and meta-analysis of randomized controlled trials in adult and children. Am J Gastroenterol 104: 3069-3079.
13. Nervi G, Liatopoulou S, Cavallaro LG et al (2006) Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? A 10 years' endoscopical survey. World J Gastroenterol 12: 2398-2401.
14. Andeica V, Pascu O, Georoceanu A et al (1998) The prevalence of Helicobacter pylori infection in medical staff. Rom J Gastroenterol 7: 243-248.
15. Sporea I, Popescu A, van Blankenstein M et al (2003) The prevalence of Helicobacter pylori infection in western Romania. Rom J Gastroenterol 12: 15-18.
16. Popescu M, Dumitrascu DL, Pascu O (2007) Low prevalence of Helicobacter pylori infection in patients with gastric cancer. Rom J Intern Med 45: 259-262.
17. De Francesco V, Margiotta M, Zullo A et al (2006) Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 144: 94-100.
18. Megraud F (2007) Helicobacter pylori and antibiotic resistance. Gut 56: 1502.
19. McDonald HP, Garg AX, Haynes RB (2002) Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 288: 2868-2879.
20. Sackett D, Snow J (1979) The magnitude of compliance and noncompliance. In: Haynes R, Taylor D, Sackett D (eds) Compliance in health care. John Hopkins University Press, Baltimore, pp 11-22.
21. Gordis L (1979) Conceptual and methodological problems in measuring compliance. In: Haynes R, Taylor D, Sackett D (eds) Compliance in health care. John Hopkins University Press, Baltimore, pp 23-25.
22. Haynes R (1979) Determinants of compliance: the disease and the mechanisms of treatment. In: Haynes R, Taylor D, Sackett D (eds) Compliance in health care. John Hopkins University Press, Baltimore, pp 49-62.
23. Haynes RB, Dantes R (1987) Patient compliance and the conduct and interpretation of therapeutic trials. Control Clin Trials 8: 12-19.
24. Zullo A, Vaira D, Vakil N et al (2003) High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 17: 719-726.
25. Sugimoto M, Furuta T, Shirai N et al (2007) Treatment strategy to eradicate Helicobacter pylori infection: impact of pharmacogenomics-based acid inhibition regimen and alternative antibiotics. Expert Opin Pharmacother 8: 2701-2717.
26. Padol S, Yuan Y, Thabane M et al (2006) The effect of CYP2C19 polymorphisms on H pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol 101: 1467-1475.
27. Sbrozzi Vanni A, Zullo A, Di Giulio E et al (2010) Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dif Liver Dis [Epub ahead of print].
28. Gisbert JP, Khorrami S, Carballo F et al (2004) H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev, article no. CD004062.